Category: News

An ASX-listed oncology company’s first-in-class cancer drug has shown encouraging clinical activity in a difficult-to-treat patient population, as per newly released results from an ongoing study.

The ASX has recognised FY22 as a record year for capital raises – with $159.4 billion invested overall – and some Aussie businesses still appear to be riding the wave of positive investor sentiment.

Every second week, we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Katana Asset Management’s Romano Sala Tenna selected Kina Securities as one of his favourite stocks, noting its sustained competitive advantage…

ASX-listed Far East Gold has been drilling down into the details of its highly prospective copper-gold Woyla project, with new data from the Phase 1 drilling program reaffirming the previously interpreted nature of the site’s Anak Perak Main Zone.

The ASX has jumped around a fair bit since last Tuesday, but it closed out yesterday’s trading session with a healthy 1.4% gain over the past week. The XTX stacked on 4.18% just yesterday, with the technology index moving with heightened volatility as investors begin to question what has been oversold and who could be a takeover target.

What if, instead of waiting a million years and spending a million dollars to mine diamonds, you could turn plastic into diamonds in the blink of an eye using lasers? Too far-fetched? Actually, that’s the world you now live in.

Artificial intelligence security company Spectur has delivered a record Q1 in FY23, with $1.657 million of revenue in sales of its solar-powered surveillance platform – a solution that MD Gerard Dyson describes as being like “the first smartphone in a world of flip-phones”.

The Federal Government has outlined a commitment to achieve 1.2 million tech jobs in Australia by 2030, and newly released data from the Australian Bureau of Statistics indicates we are headed in the right direction.

Investors have been making the same mistake over the past six months, says Lowell Resources Fund’s John Forwood, whose comments echo those made recently by Merchant’s Andrew Chapman.

Every second week we invite a leading fund manager to present at The Insider: Meet the Fund Manager. In May, Altor Capital’s Benjamin Harrison selected Pureprofile as one of his favourite stocks, noting its potential to grow its EBITDA margin…

Aussie equity markets have tempered themselves this week after the S&P 500 retreated -5.33% over the past five trading days, with the XJO shedding a modest -0.81% during the same period. The VIX stacked on over 13% as everyone braces for further volatility.

One of Australia’s leading cannabis manufacturing facilities has been formally acquired by a joint venture partner of Wellnex Life, propelling the health and wellness innovator forward in its goal to be a first mover in the emerging over-the-counter medicinal cannabis space.